Location History:
- Shenzhen, CN (2018)
- Guangdong, CN (2020 - 2021)
Company Filing History:
Years Active: 2018-2025
Title: Innovations of Tian Tang in Pharmaceutical Research
Introduction
Tian Tang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative compounds that have the potential to treat various diseases, particularly in the realm of oncology.
Latest Patents
One of his latest patents is a multi-target tyrosine kinase inhibitor. This invention relates to a compound that exhibits protein kinase inhibitory activity, which is metabolized into an active small molecule, td32-4. This compound has shown the ability to inhibit tumor growth in vivo, achieving an anti-tumor effect. Compared to td32-4, the new compound demonstrates significantly improved solubility and oral bioavailability, along with strong anti-tumor activity in animal experiments. Additionally, he has developed a crystal form of a small molecule immune compound, along with its preparation method and a pharmaceutical composition containing it. This compound has stable morphology, good chemical stability, and high temperature resistance, making it suitable for treating hyperproliferative diseases.
Career Highlights
Tian Tang is currently associated with Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. His work at this institute has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. His innovative approaches have contributed to advancements in drug formulation and efficacy.
Collaborations
Tian has collaborated with notable coworkers, including Yanqing Wang and Jing Wu. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Tian Tang's contributions to pharmaceutical research exemplify the impact of innovation in medicine. His patents reflect a commitment to developing effective treatments for serious health conditions. Through his work, he continues to advance the field and improve patient outcomes.